GGrantIndex
Sort

25,944 grants matching neurodegeneration

Genetic variant-based drug discovery targeting conserved pathways of aging

$1,876,472
Jan No Middle Name Vijg · Albert Einstein College Of Medicine · U19 · FY2020 · AG

Resource for Quantitative Functional FMRI

$1,876,065
Peter Cm Van Zijl · Hugo W. Moser Res Inst Kennedy Krieger · P41 · FY2016 · EB

Optogenetics and Transgenic Technology Core

$1,875,639
Brandon Harvey · National Institute On Drug Abuse · ZIC · FY2015 · DA

p53, Aging, and Cancer

$1,873,482
Curtis Harris · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

Innate and Adaptive Immunity in Parkinson Disease

$1,873,001
David G Standaert · University Of Alabama At Birmingham · P50 · FY2022 · NS

Resource for Quantitative Functional MRI

$1,872,748
Peter Cm Van Zijl · Hugo W. Moser Res Inst Kennedy Krieger · P41 · FY2011 · RR

The VETSA Longitudinal MRI Twin Study of Aging (VETSA MRI 4)

$1,872,740
William S Kremen · University Of California, San Diego · R01 · FY2022 · AG

Behavior and Neural Plasticity in the Aged

$1,872,590
Carl W Cotman · University Of California-Irvine · P01 · FY2009 · AG

Molecular Pathogenesis of Age-Dependent CNS Regeneration

$1,872,263
Stanley B Prusiner · University Of California, San Francisco · P01 · FY2013 · AG

Sleep and Temperature Disturbance as risk factors for Alzheimer's Disease in Down Syndrome: a Longitudinal Study

$1,871,190
Esther Marian Blessing · New York University School Of Medicine · RF1 · FY2023 · AG

Promoting circadian rhythms to optimize gut-to-brain signaling for Alzheimer's disease

$1,869,019
Girish C. Melkani · University Of Alabama At Birmingham · RF1 · FY2023 · NS

CELL AND MOLECULAR PATHOBIOLGY OF ALZHEIMER'S DISEASE

$1,867,316
Ralph A. Nixon · Nathan S. Kline Institute For Psych Res · P01 · FY2013 · AG

Treating mild cognitive impairment with transcranial direct current stimulation

$1,865,498
Benjamin Michael Hampstead · University Of Michigan At Ann Arbor · R01 · FY2021 · AG

Pro-inflammatory cytokine lowering anti-inflammatory drugs

$1,864,880
Nigel H. Greig · National Institute On Aging · ZIA · FY2021 · AG

Molecular Pathogenesis of Age-Dependent CNS Degeneration

$1,863,679
University Of California San Francisco · P01 · FY2005 · AG

AMP-AD Brain Proteomic Network Enhancement, Validation, and Translation into CSF Biomarkers

$1,861,246
Allan I Levey · Emory University · U01 · FY2020 · AG

Function and Regulation of ALDH1A1-positive Nigrostriatal Dopaminergic Neurons in Motor Control and Parkinson's disease

$1,860,870
Huaibin Cai · National Institute On Aging · ZIA · FY2021 · AG

HABS-HD - Core B - Neuroimaging & Informatics Core

$1,858,021
Sid E O'Bryant · University Of North Texas Hlth Sci Ctr · U19 · FY2023 · AG

HABS-HD - Core B - Neuroimaging & Informatics Core

$1,857,998
Sid E O'Bryant · University Of North Texas Hlth Sci Ctr · U19 · FY2024 · AG

Treating mild cognitive impairment with transcranial direct current stimulation

$1,855,907
Benjamin Michael Hampstead · University Of Michigan At Ann Arbor · R01 · FY2020 · AG

Translation dysregulation in neurodegeneration

$1,855,435
Daniela C Zarnescu · Pennsylvania State Univ Hershey Med Ctr · RF1 · FY2022 · NS

Biomarkers of Catecholaminergic Neurodegeneration

$1,854,141
David Goldstein · National Institute Of Neurological Disorders And Stroke · ZIA · FY2023 · NS

ApoE Receptor Biology and Neurodegeneration

$1,851,511
Mary Jo Ladu · University Of Illinois At Chicago · P01 · FY2010 · AG

An Extensible Resource for Genomic Analysis and Petascale Storage

$1,849,685
Harel Weinstein · Weill Medical Coll Of Cornell Univ · S10 · FY2012 · OD

Epidemiology of Biomarkers of Risk and Progression in LOAD

$1,849,084
Richard Mayeux · Columbia University Health Sciences · R01 · FY2013 · AG